PAVmed
PAVM
29 hedge funds and large institutions have $873K invested in PAVmed in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
34% more capital invested
Capital invested by funds: $654K → $873K (+$220K)
26% more funds holding
Funds holding: 23 → 29 (+6)
0.07% less ownership
Funds ownership: 0.31% → 0.25% (-0.07%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$45K |
| 2 |
LPL Financial
San Diego,
California
|
+$38.4K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$16.2K |
| 4 |
First Manhattan
New York
|
+$9.74K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$8.02K |
| 2 |
EWA
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
|
-$6.84K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$1.53K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$622 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$187 |
PAVM Hedge Fund Activity: Q1 2025 in Review
29 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q1 2025, worth a combined $873K — up 34% from $654K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PAVM positions and 3 closed out — a net gain of 6 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $45K. The largest seller was UBS Group, cutting an estimated $8.02K.
- 29 institutional investors held PAVmed (PAVM) as of Q1 2025, up from 23 in Q4 2024.
- Funds reported $873K of PAVmed stock for Q1 2025, up 34% quarter-over-quarter.
- 9 funds opened new PAVmed positions in Q1 2025 and 3 closed out, a net change of +6 holders.
- The largest PAVmed buyer in Q1 2025 was CAPTRUST Financial Advisors, an estimated $45K added.
- The largest PAVmed seller in Q1 2025 was UBS Group, an estimated $8.02K sold.
Based on aggregated 13F filings for Q1 2025.